QNXT
iShares Nasdaq-100 ex Top 30 ETF
The iShares Nasdaq-100 ex Top 30 ETF seeks to track the investment results of an index composed of the 31st -100th largest companies by market capitalization within the Nasdaq-100 Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 27.6 M
ASSETS UNDER MGMT
20 bp
EXPENSES
Fund Basics
| Inception date | Oct 24, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| AMGEN INC | 3.7 % |
| GILEAD SCIENCES INC | 3.1 % |
| MARVELL TECHNOLOGY, INC. | 3.1 % |
| WESTERN DIGITAL CORP | 3.1 % |
| ASML HOLDING NV-NY REG SHS | 3.0 % |
| SHOPIFY, INC. CLASS A | 2.8 % |
| BOOKING HOLDINGS INC. | 2.6 % |
| VERTEX PHARMACEUTICALS INC | 2.3 % |
| INTUITIVE SURGICAL INC | 2.3 % |
| STARBUCKS CORP | 2.3 % |
Constituent Breakdown
| Number of holdings | 69 |
| Herfindahl-Hirschman Index | 175 |
| Wgt avg mkt cap (mns) | $116,659 |
| Large cap (>$10bn) | 93.2% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 91.7% |
| Emerging mkts. | 2.8% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 80.8 % |
 |
NETHERLANDS | 5.0 % |
 |
BRITAIN | 3.0 % |
 |
CANADA | 2.8 % |
 |
ARGENTINA | 1.7 % |
 |
CHINA | 1.1 % |
Historical Performance
Standardized Performance (as of 07/26/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -- |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -- | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 16 |
| ADV traded (mns) | $0 |
| Turnover | 1.7% |
| Avg. Bid/Ask (% of price) | 0.07% |
Technical Indicators
| 30d moving avg. (EMA) | $30.80 |
| Relative strength (RSI) | 49 |
| MACD/Signal | -0.06/0.09 |
| Bollinger Bands (Upper/Lower) | $31.75/$30.30 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. QNXT |
Expenses vs. QNXT |
ALTAR Score™ vs. QNXT |
|---|---|---|---|---|
| QQQE | Direxion NASDAQ-100 Equal Weighted Index Shares | 54.0% | +15 bp | -0.8% |
| QQXT | First Trust Nasdaq-100 Ex-Technology Sector Index Fund | 51.9% | +40 bp | -0.1% |
| QQEW | First Trust Nasdaq-100 Equal Weighted Index Fund | 43.8% | +38 bp | -0.8% |
| QQQG | Pacer Nasdaq 100 Top 50 Cash Cows Growth Leaders ETF | 34.8% | +29 bp | -1.5% |
| QTEC | First Trust NASDAQ-100 Technology Sector Index Fund | 33.0% | +37 bp | -1.7% |
| USRD | Themes US R&D Champions ETF | 25.5% | +9 bp | -0.3% |
| VOT | Vanguard Mid-Cap Growth ETF | 23.7% | -13 bp | -0.9% |
| MFIG | Motley Fool Innovative Growth Factor ETF | 23.2% | +30 bp | -1.2% |
| QNDX | State Street SPDR Portfolio Nasdaq 100 ETF | 22.7% | -10 bp | -0.7% |
| IQQ | iShares Nasdaq 100 ETF | 22.4% | -10 bp | -0.6% |
Risk and Returns: QNXT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/26/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.0%
ALTAR SCORE™
42nd
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. QNXT's ALTAR Score™ is approximately -0.2 standard
deviations above the category average. This places QNXT in the 42nd percentile
among funds in the category.
Sell-Side Consensus
$33.89
PRICE TARGET
+13.0%
UPSIDE